New patents in Taiwan's infant biotechnology industry hit a brick wall when they reach the government's regulatory body, as there aren't enough examiners to cope with the workload, experts said yesterday.
"The speed of the review process is quite slow as there are very few biotechnology reviewers at the Intellectual Property Office [IPO]," said Liang Chi-ming (
Liang was speaking on the second and final day of a Taiwan-Europe government-level joint seminar on intellectual property rights (IPR) protection and enforcement in Taipei yesterday.
Taiwan currently has 150 patent examiners, according to statistics from the IPO, which is under the Ministry of Economic Affairs. The vast majority work on information technology innovations, such as computer chip circuit design.
Reviewers dedicated to biotechnology and medicine number as few as 20. Another 50 examiners are being recruited this year, but only two will be assigned to biotech, sources at the IPO said yesterday without giving their names.
Biotech companies are feeling the pinch.
"The IPO does not have enough examiners with a biotechnology background," Ben Liang (
"They often have to outsource the work to universities which have the technical knowledge, but don't have the professional patent knowledge, so cases are passed back and forth. It takes us three to five years to get a patent," Liang said.
But Taiwan may not be unique in having a backlog of biotech patents pending.
"Biotech is a new field and the patent process takes a long time as not enough people have the relevant background or knowledge," Liang said.
"It also takes two to three years to get a patent in the US, and even up to 10 years in a controversial case," he said.
The US Patent and Trademark Office is also trying to simplify the patent application procedure for biotech inventions.
The office intends to limit the number of inventions claimed in one application to speed up the process, according to a statement on its Web site dated Monday.
Taiwan is now addressing the problem.
"There are currently very few biotech patent reviewers, but next year we will have a new system for utilizing patent number registration that could save manpower in this field," Hsieh Ming-yang (
From 1976 until the end of last year, the IPO granted almost 20,000 patents in the field of biotechnology and related areas, its statistics show.
Of those, 56 were for Chinese herbs, 8,019 for biotechnology innovations and 10,669 for medicines.
DECOUPLING? In a sign of deeper US-China technology decoupling, Apple has held initial talks about using Baidu’s generative AI technology in its iPhones, the Wall Street Journal said China has introduced guidelines to phase out US microprocessors from Intel Corp and Advanced Micro Devices Inc (AMD) from government PCs and servers, the Financial Times reported yesterday. The procurement guidance also seeks to sideline Microsoft Corp’s Windows operating system and foreign-made database software in favor of domestic options, the report said. Chinese officials have begun following the guidelines, which were unveiled in December last year, the report said. They order government agencies above the township level to include criteria requiring “safe and reliable” processors and operating systems when making purchases, the newspaper said. The US has been aiming to boost domestic semiconductor
Nvidia Corp earned its US$2.2 trillion market cap by producing artificial intelligence (AI) chips that have become the lifeblood powering the new era of generative AI developers from start-ups to Microsoft Corp, OpenAI and Google parent Alphabet Inc. Almost as important to its hardware is the company’s nearly 20 years’ worth of computer code, which helps make competition with the company nearly impossible. More than 4 million global developers rely on Nvidia’s CUDA software platform to build AI and other apps. Now a coalition of tech companies that includes Qualcomm Inc, Google and Intel Corp plans to loosen Nvidia’s chokehold by going
ENERGY IMPACT: The electricity rate hike is expected to add about NT$4 billion to TSMC’s electricity bill a year and cut its annual earnings per share by about NT$0.154 Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has left its long-term gross margin target unchanged despite the government deciding on Friday to raise electricity rates. One of the heaviest power consuming manufacturers in Taiwan, TSMC said it always respects the government’s energy policy and would continue to operate its fabs by making efforts in energy conservation. The chipmaker said it has left a long-term goal of more than 53 percent in gross margin unchanged. The Ministry of Economic Affairs concluded a power rate evaluation meeting on Friday, announcing electricity tariffs would go up by 11 percent on average to about NT$3.4518 per kilowatt-hour (kWh)
OPENING ADDRESS: The CEO is to give a speech on the future of high-performance computing and artificial intelligence at the trade show’s opening on June 3, TAITRA said Advanced Micro Devices Inc (AMD) chairperson and chief executive officer Lisa Su (蘇姿丰) is to deliver the opening keynote speech at Computex Taipei this year, the event’s organizer said in a statement yesterday. Su is to give a speech on the future of high-performance computing (HPC) in the artificial intelligence (AI) era to open Computex, one of the world’s largest computer and technology trade events, at 9:30am on June 3, the Taiwan External Trade Development Council (TAITRA) said. Su is to explore how AMD and the company’s strategic technology partners are pushing the limits of AI and HPC, from data centers to